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The intravenous injection of4-hydroxy-3-nitrophenyl  acetyl hapten (NP)1-modified 
syngeneic spleen  cells  results  in  profound  suppression  of contact  sensitivity  (CS), 
delayed-type hypersensitivity (DTH), and plaque-forming cell (PFC) responses (1-9). 
This hapten-specific suppression is mediated by a cascade of T  cell interactions. The 
first  cell  in  the  pathway  responsible  for suppression  of CS  and  PFC  responses  is 
present in spleens of mice treated 7 d previously with an intravenous injection of NP- 
coupled spleen  cells  (1). A  hybridoma line  derived  from this  population secretes  a 
suppressor factor capable of inducing a second-order, effector-phase suppressor T  cell 
population (Ts2) in vivo (2). The Ts2 suppressor cell population interacts directly with 
an I-J-bearing, NP-specific T  cell population (Ts3) induced in NP-primed mice (5, 9). 
The ultimate effect of this suppressor T  cell pathway is the specific suppression of CS 
responses  to  NP  (2-5)  and  preferential  suppression  of NP  b idiotype-bearing B  cell 
clones both in vivo (6) and in vitro (7). 
All of the studies performed in the PFC system have involved heterogeneous cell 
populations obtained either  directly from spleens  of treated  mice or from cultures. 
The results indicate that a similar suppressor T  cell pathway may affect both T  cell- 
mediated CS and B cell-mediated PFC responses. The purpose of the present studies 
was to determine whether the same T cells within these mixed populations are capable 
of suppressing both CS and  PFC responses.  To this end, cloned T  cell hybridomas 
corresponding to the Tsl and Ts3 populations were prepared.  We demonstrate that 
the hybridoma-derived factors previously shown to suppress in vivo CS responses also 
suppress the in vitro PFC responses, despite  the difference in target populations.  In 
addition,  the characteristics  of these  hybridomas and  the  biologically active  factor 
that  they secrete are compared.  The data  indicate  that,  whereas  both  hybridoma- 
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derived factors  have NP-binding receptors  and express  I-J- and Npb-related deter- 
minants, they can be distinguished on the basis of kinetics of suppression, ability to 
induce effector-phase  suppressor  cells,  and  ability to  replace  Tsa  populations.  In 
addition, the factor secreted by the Ts3 hybridoma probably interacts directly with B 
lymphocyte targets and has two chains, only one of which binds NP. 
Materials and Methods 
Mice.  Male C57BL/6 mice were purchased from The Jackson Laboratory, Bar Harbor, 
ME. All animals were between 8 and 12 wk of age at the time of immunization. Animals were 
age matched in each experiment. 
Animals used  in  this  study  were  maintained in  accordance  with  the  guidelines of the 
Committee on Animals of the Harvard Medical School and those prepared by the Committee 
on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, 
National Research Council (Dept.  of Health, Education, and Welfare Publication (NIH) 78- 
23, revised 1978). 
Antigen.  NP-bovine  serum albumin (BSA), NP-keyhole limpet hemocyanin (KLH) and NP- 
Ficoll were conjugated by the reaction of NP-O-succinimide (NP-O-Su)  (Biosearch  Inc., San 
Rafael,  CA)  with  BSA,  KLH  (Sigma Chemical Co.,  St.  Louis, MO),  or N-(2-aminoethyl) 
carbanylmetllylacetyl (AECM)-Ficoll (Biosearch)  as  described  (6). The NP-BSA, NP-KLH, 
and NP-Ficoll had an average of 12, 30, and 17 NP groups per 100,000 daltons, respectively. 
NP-Brucella abortus (BA) was prepared by the reaction of 1 mg NP-O-Su in dimethyl formamide 
with  1 ml of stock  BA  (Ring Test antigen, U.  S.  Department of Agriculture, Ames, IA) in 
Na2CO3 buffer,  pH  8.0.  Trinitrophenyl hapten  (TNP)-BA was  prepared  according to  the 
method of Mond et al. (10). 
Immunization.  Responder cells for in vitro cultures or for generation of Ts3 populations were 
obtained from mice immunized intraperitoneally  4 wk previously with 50 #g of NP-KLH in a 
0.2-ml mixture containing 25%  pertussis vaccine (Michigan Department of Public Health, 
Lansing, MI). 
Suppressor T  Cell Populations.  Ts2  suppressor  cell  populations were  obtained by  the  4-d 
subculture of spleen cells from mice treated 7 d previously with NP-coupled syngeneic spleen 
cells as described (7). Ts3 suppressor cell populations were obtained from spleen cells of mice 
immunized 4 wk previously with NP-KLH (9). T  cell-enriched populations were obtained by 
passage over rabbit anti-mouse immunoglobulin  (RAMG)-coated petri dishes according to the 
procedure of Mage et al.  (11). T  cells purified on RAMG-coated dishes were <2% immuno- 
globulin positive as determined by fluorescence analysis. 
Suppressor T Cell Hybridomas and Suppressor Factors.  The generation of the B6-Tsl-29 hybrid- 
oma has been described  (2). Briefly,  spleen cells  from mice treated  7 d  previously with an 
intravenous  injection  of NP-coupled syngeneic spleen cells were hybridized with BW5147 tumor 
cells. Supernatants from cloned hybridoma cells that carried I-J  b- and Npb-related idiotypic 
cell surface markers were tested for biological activity as described (2, 3). 
The production of the B6-Tsa-8 hybridoma by fusion of BW5147 with T cells from C57BL/ 
6 mice that received an intravenous injection of NP-coupled syngeneic spleen cells is detailed 
elsewhere  (4). The hybridoma cells were screened by a cytotoxicity test with anti-I-J  b alloanti- 
serum.  The  B6-Ts3-8  cell  line was  cloned  and  factors  derived  from  this  line  have  been 
characterized in the CS system (4). Several hybridomas corresponding to Ts2 suppressor cells 
were simultaneously  obtained from this fusion and are described elsewhere  (3). 
All hybridomas were cultured in RPMI  1640 containing 8% fetal calf serum and 0.01  M 
Hepes buffer. The supernatants used in the present experiments as the source for suppressor 
factor were collected from cultures at a density of ~7.5 x  l0  p cells/ml. Pools of supernatants 
were frozen at -70°C in aliquots. 
Responder Cultures.  Spleen cells from C57BL/6 mice immunized 4 wk previously with NP- 
KLH or TNP-KLH were teased into a  single-cell suspension under sterile conditions. Cells 
were washed and resuspended in Mishell-Dutton medium containing 10% fetal calf serum. 7.5 
×  106 viable primed cells were added to each well of a  16-mm culture plate. Cultures were 
challenged with 200 ng of NP-Ficoll, a  1:20 dilution of NP-BA, or 1:80 dilution of TNP-BA in SHERR,  MINAMI, OKUDA, AND DORF  517 
40 pl minimal essential medium (MEM). Sheep red blood cell (SRBC)-specifie PFC responses 
were induced by the addition of 2 ×  10  e SRBC to cultures of 7.5 ×  10  e normal C57BL/6 spleen 
cells. Cultures were incubated in rocking boxes at 37°C in a  10% CO2 atmosphere and fed daily 
with 0.1 ml of supplementary medium. 5 d after challenge, duplicate wells were pooled, washed, 
and assayed for direct NP- or SRBC-specific PFC responses on triplicate slides in a modified 
Jerne plaque assay (12). 
Anti-I-J  and Anti-Thy-l.2  Antiserum  Treatments.  2  ×  10  s  spleen cells from  C57BL/6  mice 
immunized 4 wk previously with NP-KLH were washed in MEM, pelleted, and treated with 
0.3 ml of 5R anti-3R (anti-I-J  b) or AKR anti-CBA thymocyte (anti-Thyl.2) antiserum diluted 
1:5 in MEM for 30 min at room temperature. Cells were then washed, pelleted, and treated for 
30 min at 37°C with 0.3 ml of rabbit complement (C) diluted 1:5 in MEM containing 0.01 
mg/ml  DNase.  Cells were washed,  resuspended in  Mishell-Dutton medium,  and  7.5  ×  106 
viable cells were added to each well. The  anti-I-J  b antiserum  used  in  these experiments is 
capable of preventing the induction of transferable suppressor cells in vivo (13) and of lysing at 
least two distinct subpopulations of suppressor cells, i.e., Ts2  and Ts3 cells (3,  9).  The anti- 
Thyl.2 antiserum consistently ablates in vitro responsiveness to the T-dependent antigens NP- 
poly-L-Gly56-L-Lys35-L-Phe  9 (GL~) and NP-ovalbumin (data not shown). 
5R anti-3R and 3R anti-5R antisera were used to prepare immunoadsorbent columns. The 
anti-I-J antiserum-containing columns had biological activity, as demonstrated by their ability 
to adsorb Ts2 and Ts3 factor from B6 and CKB mice (3, 4). 
NP  b Idiotype.  The  preparation of affinity-purified C57BL/6  anti-NP  antibody has been 
detailed elsewhere (8). 
Anti-NP  b Idiotypic Antiserum.  Guinea pigs were hyperimmunized with  100  /~g of purified 
C57BL/6  anti-NP antibodies in complete Freund's adjuvant  as detailed elsewhere (8).  The 
anti-idiotypic antisera were  extensively adsorbed with  columns  conjugated with  y-globulin 
fractions of MOPC-104E (#,)k) and (C57BL/6 ×  DBA/2)F~ ascitic fluid. The adsorbed antisera 
did not react with IgM, IgG, k, or )k chains by Ouchterlony analysis. 
Columns.  All  columns  were  prepared  by  the  reaction  of protein  with  CNBr-activated 
Sepharose 4B (Sigma Chemical Co., St. Louis, MO) as described (4). The coupling efficiency 
was routinely >90%. 
Reduction of  Suppressor Factor.  The B6-Ts3-8-derived hybridoma factor was reduced according 
to the method of Taniguchi et al. (14).  Briefly described, B6-Ts3-8  factor was reduced with 5 
mM dithiothreitol (DTT) at room temperature for 45 min. The reduced factor was then passed 
over immunoadsorbent columns under reducing conditions (i.e., under N2) and eluted with 0.2 
M glycine-HC1 (pH 3.0) as described (15). Filtrates, eluates, or mixtures of the column fractions 
were then dialyzed extensively against PBS. 
Statistics.  Results were analyzed with a two-tailed Student's t test. 
Results 
NP-specific Suppression  of PFC Responses  In  Vitro with B6-Tsl-29 and B6-Tsa-8 Hybrido- 
mas.  It  has  been  demonstrated  that  hybridoma  factor  derived  from  first-order 
suppressor T  cells  (Tsx)  can  induce  effector-phase suppressor cells in  vivo  (2).  The 
activity and specificity of the B6-Tsa-29-derived hybridoma factor to suppress in vitro 
PFC responses was compared with another NP-specific hybridoma-derived suppressor 
factor,  B6-Tss-8,  both  of which  were  previously characterized  for suppression  of T 
cell-mediated CS responses (2, 4). Cells or supernatants from BW5147 thymoma, B6- 
Tsl-29, or B6-Ts3-8 hybridoma cell cultures were added to NP-KLH-primed or normal 
responder cells challenged with NP-Ficoll or SRBC  (Table I). For these experiments, 
the Tsa factor (TsF1)  was given during the induction phase  (day 0), whereas the Ts3 
factor  (TsF3)  was  added in the terminal  phase  (day 4)  of the 5-d culture period.  5 
days after antigen  challenge, cultures were  assayed  for NP-  or  SRBC-specific PFC 
responses. The results presented in Table I  indicate that both B6-Tsl-29 and B6-Ts3- 518  SUPPRESSION  OF  B  CELL  RESPONSES 
TABLE  I 
NP-Spec~c Suppression of In  Vitro PFC Responses with  Ts, or Ts3 
Hybridoma  Cells or Supernatants * 
Experi-  NP-specific PFC/  SRBC-specific 
mental  Cells or supernatant added  culture X+ log  PFC/cuhure +  × 
series  SE~:  log SE 
1  BW5147  supernatant  1,300 ~  1.2  730  X+  1.4 
B6-Tsa-29 supernatant  420  ~  1.2{}  840  ~  1.3 
2  BW5147  cells  1,710 X_.. 1.3  1,380 X+  1.5 
B6-Ts3-8 cells  400  X+  1.5§  1,400 X+  1.6 
3  BW5147  supernatant  2,100  x+  1.4  2,930  x+  1.3 
B6-Tsa-8 supernatam  600  X+  1.5{}  3,100  X+  1.7 
* 2.5  ×  10  ~ viable  BW5147  thymoma or Ts3-8  hybridoma cells  or 40  /~1  of 
BW5147,  B6-Ts~-29, or B6-Ts3-8 culture supernatants were added  to  7.5  X 
10  6 NP-KLH-primed or unprimed responder cells the day of (B6-Ts,-29)  or 
4 d  after  (B6-Tsa-8)  challenge with 200  ng of NP-Ficoll or 2 ×  l0  s SRBC. 
Cultures were assayed for NP- or SRBC-specific direct  PFC  responses 5  d 
after antigenic challenge. 
:~ Data  are  expressed  as  the  geometric  mean  of  the  PFC  response  X+  log 
standard  error.  Results were obtained  from three  to  nine experiments for 
each series. 
§ Significant level of suppression relative to BW 5147 controls, P <  0.05. 
TABLE  II 
B6- Tsl-29 and B6- Tsa-8 Factors Bind NP* 
Immunoadsorbent  Column fractions 
column 
Percent suppression of anti-NP 
PFC +  SE:}: 
B6-Ts,-29  B6-Tsa-8 
None  --  86+8  45±8 
NP-BSA  Filtrate  -21 ±  30  -7 ±  14 
NP-BSA  Eluate  71  ±  13  52 ±  10 
BSA  Filtrate  78 ±  11  NT§ 
BSA  Eluate  27 ±  9  NT 
NP  b  Filtrate  NT  40 +  15 
NP  u  Eluate  NT  8 ±  5 
* Supernatants from cultures of B6-Tsl-29 or B6-Ts3-8  hybridoma cells  were 
passed over immunoabsorbent columns as indicated. 40/~1 of column filtrates 
and eluates or supernatants from BW5147  thymoma cultures were added to 
7.5 X  106 NP-KLH-primed responder ceils challenged on the same day (B6- 
Tsl-29) or 4 d previously (B6-Tsa-8) with NP-Ficoll. Cultures were assayed 5 
d after antigenic challenge for direct NP-specific PFC responses. 
Data are presented as the arithmetic means of percent suppression from two 
(B6-Ts~-8)  or  three  to  six  (B6-Ts~-29)  experiments  ±  SE.  The  geometric 
means of the control responses in separate experimental series  for B6-Tsa-29 
×  ×  and B6-Ts3-8 were 2,260  +  1.4 and 7,300  +  1.3, respectively. 
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8 supernatants significantly  reduced the NP-specific PFC responses. These suppressive 
activities were NP specific, since the response to SRBC was unaffected (Table I). 
TsF1 and  TsFa  Both  Bind NP.  To  determine the  binding specificity of the  two 
hybridoma products, supernatants from cultures of B6-Tsl-29 or B6-Tsa-8 hybridoma 
cells were passed over immunoadsorbent columns as indicated in Table II. Column 
filtrates or acid eluates were tested for their ability to suppress when added either in 
the induction (B6-Tsx-29) or effector (B6-Tsa-8) phase of the PFC response. The results 
indicate that both hybridoma factors specifically bound to NP-BSA. B6-Tsa-29 factor 
did  not  significantly bind BSA-coupled  immunoadsorbent columns. The  binding 
specificity of the B6-Tsa-8 factor was further demonstrated by its inability to bind to 
columns coupled with anti-NP antibodies containing NP  b idiotype. The ability of the 
B6-Tsa-8 hybridoma factor to bind antigenic and not idiotypic determinants suggests 
that the cell from which it is derived corresponds to the third-order, effector-phase, 
NP-specific Ts3 population (4, 9)  and not the second-order, Npb-specific, Ts2 popu- 
lation (7, 8). As a  control for the NP  b immunoadsorbent columns, hybridoma factor 
derived from second-order Ts2 cells (B6-Ts2-28) was specifically absorbed and eluted 
from the NP  b idiotype column (data not shown). 
TsFt and  TsFa Express l-J b- and NPb-Related Determinants.  To further characterize 
the B6-Tsx-29 and B6-Tsa-8 factors, supernatants were passed over rabbit anti-mouse 
immunoglobulin,  guinea pig anti-NP  b idiotype, anti-I-J  b or anti-I-J  k antiserum-cou- 
pled immunoadsorbent columns as indicated in Table III. Column filtrates and acid 
eluates were tested for their ability to suppress in vitro PFC responses in the induction 
(B6-Tsr29)  or  effector  (B6-Tsa-8)  phase.  Data  presented in Table III demonstrate 
that the B6-Tsr29- and B6-Tsa-8-derived factors, which are capable of suppressing 
PFC  responses,  bear  both  I-J  b-  and  Npb-related  idiotypic  determinants;  that  is, 
suppressive activity measured in the PFC system was detected in the eluates from I-J  b 
TABLE  III 
Characterization of B6- Tst-29 and B6- Tsa-8 Factors* 
Immunoadsorbent column  Column fraction 
Percent suppression  of anti- 
NP response ± SE:~ 
B6-Tsr29  B6-Tsa-8 
Anti-mouse immunoglobulin  Filtrate  NT§  55 +_ 19 
Anti-mouse immunoglobulin  Eluate  NT  -6 -I- 1 
Anti-NP  b  Filtrate  11 ± 9  -28 ± 32 
Anti-NP  b  Eluate  88 ±  12  33 ± 9 
Anti-I-J  b  Filtrate  4 ± 9  4 ± 6 
Anti-I-J  b  Eluate  81 ±  19  51 ±  11 
Anti-I-J  k  Filtrate  NT  37 ± 9 
Anti-I-J  k  Eluate  NT  8 ±  19 
* Supernatants  from cultures of BW5147 thymoma,  B6-Tsa-29 hybridoma, or  B6-Tsa-8 
hybridoma cells were passed over immunoadsorbent columns. 40/tl of the filtrate or the 
acid eluate was added to NP-KLH-primed responder cells on the day of (B6-Tsr29) or 4 
d after (B6-Tss-8) challenge with NP-FicolI. All cultures were assayed 5 d after challenge 
for direct PFC responses. 
Data are expressed as the arithmetic mean of percent suppression of PFC responses from 
two  (B6-Ts3-8) or  three  (B6-Tsr29) experiments +  SE.  Control responses of separate 
experimental series ranged from 1,650 to 9,200 PFC. 
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and  NP  b  idiotype  columns.  Specificity  controls  included  the  demonstration  that 
C57BL/6  (Igh b)-derived TsFa factor does not express immunoglobulin  or I-Jk-encoded 
determinants  (Table III). 
Kinetics  of Suppression  with  Hybridoma  Supernatants.  Because  the  antigen-binding 
specificity of factor secreted by the B6-Tsl-29 hybridoma  was the same as that secreted 
by the  B6-Tsa-8  hybridoma  and  because  they  both  expressed  I-Jb-encoded  and  NP b 
idiotypic determinants,  it was important  to differentiate between the two hybridomas 
or between their factors. To compare the kinetics of suppressive activity, B6-Ts~-29 or 
B6-Tsa-8 supernatants  were added  to  NP-KLH-primed  responder  cultures,  either at 
the  time ( f  antigenic  challenge  (induction  phase)  or 3-4  d  after antigenic  challenge 
(effector phase).  Cultures  were assayed  5  d  after  the  addition  of antigen.  The  data 
presented  in  Table  IV  indicate  that  whereas  B6-Tsl-29  and  B6-Tsa-8  supernatant 
suppressed the response when added in the induction phase, only B6-Tsa-8 supernatant 
suppressed  when  added  in  the  effector  phase.  The  suppression  observed  after  the 
addition of B6-Tsl-29 or B6-Tsa-8 supernatants  in the induction phase was NP specific 
inasmuch as the response to SRBC was not altered. The hybridomas differ, then, with 
regard  to  their  ability to  specifically suppress  responses  when  added  in  the  effector 
phase.  The  difference  in  kinetics  of suppression  apparently  is  not  due  to  a  higher 
concentration  of B6-Tsa-8 factor, because B6-Tsl-29 factor was effective at concentra- 
tions  10-100  times lower than  B6-Tsa-8  factor when  both  factors  were added  in  the 
induction  phase  (data not shown). 
Induction  of Effector-Phase Suppressor  Cells with  TsF1 but not  TsF3.  The administration 
of B6-Tsl-29  factor  in  vivo  induces  Ts2  suppressor  cells,  which  can  affect  contact 
sensitivity and  PFC  responses  (2).  To compare  the abilities of B6°Tsl-29 and  B6-Tsa- 
8  hybridoma  factors  to  induce effector-phase  suppressor  cells in  vitro, normal  spleen 
TABLE  IV 
Comparison of the Ability of B6-TSl-29 and B6-Tsa-8 Factors to Suppress in 
the Induction and Effector Phases of the PFC Response * 
Supernatant 
Percent sup- 
Percent suppression  of anti-NP  pression of 
respons@  anti-SRBC 
response 
Induction  Induction 
phase  Effector phase  phase 
B6-Tsl-29  70 +  21§  -11 ±  16  -30 -+ 3 
B6-Tsa-8  69 ±  13§  59 ±  14§  -17 ± 4 
40 #l of supernatants  from BW5147 thymoma, B6-Tsl-29 hybridoma, or B6- 
Tsa-8 hybridoma  cell cuhures  were  added  to normal  or NP-KLH-primed 
responder  cells at the time of challenge with NP-Ficol] or SRBC (induction 
phase)  or 3-4 d  thereafter  (effector phase).  All cultures  were  assayed  5 d 
after antigen challenge for direct NP- or SRBC-specific  PFC responses. 
z~ Data are expressed as the arithmetic means of percent suppression  relative to 
BW 5147 controls  +_  SE.  Data ~ooled  from  two  to  four experiments are 
presented.  The geometric  mean +  x  SE of the responses of NP-KLH-primed 
cultures  to  which  BW  5147 supernatant  was  added  in  the  induction  or 
effeetor  phases  was  3,960 ×  +  1.6 and 4,830 +X  1.1, respectively.  The control 
response to SRBC was 1,850 X.. 2.4. 
§ Significant  level of suppression  relalive to response of cultures  to which B6- 
Tsl-29 supernatant was added in the effeetor phase,  P <  0.04. SHERR,  MINAMI, OKUDA, AND  DORF 
TABLE  V 
Comparison of the Ability of B6-Tsr29 and B6-Tsa-8 Factors to Induce 
Suppressor Cells In  Vitro* 
Factor added 
Percent suppression ± SE~: 
NP-specific PFC  SRBC-specific  PFC 
B6-Tsa-29  75 _+ 10§ (7)  -32 +  I0 (2) 
B6-Tss-8  -13 -  24  (8)  NT[[ 
* 7.5  ×  106 normal spleen cells from C57BL/6 mice were cultured  in the 
absence of antigen for 4 d. On day 0, 10 40 #1 of supernatant from cultures 
of BW5147 thymoma, B6-Tsl-29  cells, or B6-Tsa-8  cells were added. 10 pl of 
these supernatants were added on days 1, 2, and 3. On day 4, cultured cells 
were washed extensively  and 5 ×  105 viable ceils were added to NP-KLH- 
primed or normal responder cells challenged 4 d previously with NP-Ficoll 
or SRBC, respectively. 1 d later, all cultures were assayed for NP- or SRBC- 
specific PFC  responses. The  geometric mean  +  ×  log SE  of the  NP  and 
SRBC control responses was 1,240 ~  1.2 and 1,360 +x 3.2, respectively. 
:~The  data  are  presented as  the  arithmetic  mean  _+  SE  of  the  percent 
suppression, relative to BW 5147 controls. 
§ Significant level of suppression relative to  B6-Tsa-8 supernatant-treated 
cultures, P < 0.007. 
[[ Not tested. 
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cells were cultured for 4  d  in the presence of supernatants from BW5147 thymoma, 
B6-Tsx-29,  or  B6-Tsa-8  hybridoma  cultures.  Cultured  cells  then  were  extensively 
washed  and  added  to  normal or  NP-KLH-primed responder cells  challenged 4  d 
previously with NP-Ficoll or SRBC. Cultures were assayed 1 d later for PFC responses. 
The data presented in Table V  extend previous in vivo experiments on the ability of 
B6-Ts1-29 supernatant to induce NP-specific, Ts2 suppressor cells (2) by demonstrating 
a  similar  inductive capacity  in  an  in  vitro  induction system.  In  contrast,  under 
identical conditions, supernatants from B6-Tsa-8 hybridoma cultures failed to induce 
active suppressor cells. Thus, the hybridoma-derived factors differ in their ability to 
induce effector-phase suppressor cells in vitro. 
Suppression  of Anti-I-J b  +  C-treated  Responder  Cells  with  TsF3 but not  TsFI Hybridoma 
Supernatant.  Because  addition of B6-Tsr29  factor  may result  in  the  activation of 
effector-phase suppressor cells (Ts2 and/or Ts3 populations), it would be expected that 
the  elimination of these  I-J-bearing populations or  their  precursors  with  anti-I-J 
antiserum plus C  would ablate the ability of B6-Ts1-29 supernatant but not that of 
B6-Tss-8 supernatant to suppress the NP-specific PFC response. To test this hypothesis, 
supernatants from B6-Tsl-29 or B6-Ts3-8 cultures were added to  untreated or anti- 
I-J  b antiserum plus C-treated responder cells at  the time of antigenic challenge. To 
ensure  that  treatment  of  responder  populations  with  anti-I-J  b  antiserum  plus  C 
eliminated I-Jb-bearing cells, each experiment included groups in which Ts2 and/or 
Ts3 populations were added to anti-I-jb-treated  responder cells as described previously 
(9). As indicated elsewhere (5, 9,  16), the failure of active Tsz populations to suppress 
was  an  indication of the  functional elimination of the  I-J-bearing Tsa  population 
(data not shown). The data presented in Table VI show that, although supernatants 
from  B6-Tsr29 or  B6-Tss-8 hybridoma cultures may specifically suppress  anti-NP 
responses when added in the induction phase to untreated responder cultures, as has 
been  demonstrated  in  a  separate  series  of experiments  (Table  IV),  only B6-Tss-8 522  SUPPRESSION  OF B CELL RESPONSES 
TABLE VII 
Comparison of the Ability of B6-Tsl-29 and B6-Ts:r8 Supernatants to 
Suppress Anti-l-J b Plus C-treated Responder Cells * 
TsF added  Day  Treatment of responder  Percentsion  of anti-NpSUppres- 
added  cells  response + SE:~ 
B6-Tsl-29  0  --  66 --- 9§ 
B6-Tsa-8  0  --  68 +  13§ 
B6-Tsl-29  0  Anti-I-J  b plus C  4 --- 6 
B6-Ts3-8  0  Anti-I-J  b plus C  61 +- 6§ 
B6-Tsa-8  4  Anti-I-J  b plus C  81 + 9§ 
* 40 #l of supernatant from BW5147 thymoma, B6-Tsx-29 hybridoma, or B6- 
Ts~-8 hybridoma cultures were added to NP-KLH-primed responder cultures 
at the time of (day 0) or 4 d  after (day 4) challenge with NP-FicoI1. Where 
indicated, responder cultures had been treated with antM-J  u antiserum plus 
C before culture. All cultures were assayed 5 d after challenge for direct NP- 
specific PFC responses. 
:~ Data are presented as the arithmetic mean of percent suppression relative to 
BW 5147 controls from three to six experiments ziz SE. The geometric means 
of control  responses  for  untreated  and  anti-I-J  plus  C-treated  responder 
cultures to which BW 5147 supernatant was added were  3,220  +  1.7  and 
4,430 X+ 1.3, respectively. 
§ Significant level of suppression relative to the percent suppression of anti-I- 
J  plus C-treated cultures to which B6-Tsl-29 supernatant was added, P  < 
0.02. 
supernatants  were capable of suppressing  the response of anti-I-J antiserum  plus  C- 
treated  responder cells when added in the induction or the effector phase.  Thus, the 
B6-Tsa-29 and  B6-Tsa-8 hybridoma factors are  distinguishable  on the  basis  of their 
ability to function in the absence of I-Jb-bearing target cells. 
B6-Tsa-8  Hybridoma  Factor  is  a  Two-Chain  Molecule.  Inasmuch  as  B6-Tsa-8  factor 
bears  products  linked  to  the  Igh  (Npb-related  idiotype)  and  the  H-2  (I-J)  gene 
complexes, it may be hypothesized that  two gene products may be required  to form 
the  functional  Tsa  suppressor  factor.  Indeed,  recent  evidence  has  suggested  that 
antigen-binding  suppressor  factors  may  be  separated  by  reduction  (14,  15,  17)  or 
digestion  (18)  into two moieties.  To examine the structural  organization of B6-Ts3-8 
factor,  ascites  fluid  induced  with  B6-Ts3-8 cells was passed  over NP-BSA immuno- 
adsorbent  columns.  The  acid  eluate  (purified  B6-Ts3-8-derived  factor)  was  then 
reduced with 5 mM DTT. Some of the reduced factor was dialyzed, and the remainder 
was passed over an NP-BSA column. The filtrate,  acid eluate,  or a  combination  of 
these two factors was dialyzed against  PBS. The B6-Ts3-8 fractions were then tested 
for their ability to suppress when added in the effector phase.  The data presented  in 
Table VII substantiate  previous finding (Table II) that B6-Ts3-8 factor binds to and 
can be eluted from NP-coupled immunoadsorbent columns. Reduction of the purified 
factor does not eliminate  its ability to suppress NP-specific PFC response.  However, 
separation  of the  reduced  factor into  NP-binding  and  nonbinding  fractions reveals 
that neither fraction alone is capable of significantly suppressing the PFC response in 
comparison to reduced unfractionated Ts3. In some experiments we observed activity 
in the fraction containing the reduced filtrate.  This was not, however, consistent.  In 
contrast,  significant  levels  of suppression  can  be  consistently  reconstituted  when  a 
combination  of the  filtrate  and  the  eluate  is  added  in  the  effector  phase  of the SHERR,  MINAMI, OKUDA, AND  DORF 
TABLE  VII 
Immunochemical Characterization of B6-Tsa-8 Factor* 
Reduc-  NP-BSA immunoadsorb- 
tion  ent column fraction 
Percent suppression  ±  SE~ 
NP specific  SRBC specific 
-  eluate  100 + 0§  2 --- 6 
+  --  68+  12§  22+  13 
+  filtrate  31 -  14  -.5 ±  1 
+  eluate  5±8  -11  ±4 
+  filtrate plus eluate  62 ±  13§  0 ±  5 
* B6-Ts3-8-induced  ascites  was  passed over NP-BSA  immunoadsorbent col- 
umns.  An aliquot  of the acid eluate  (purified  B6-Ts,-8  factor)  was then 
reduced with 5 mM DTT.  An aliquot of the reduced factor was dialyzed 
against PBS while the remainder was passed over another NP-BSA immu- 
noadsorbent column under reducing conditions. The filtrate,  acid eluate, or 
combination of these fractions was dialyzed against  PBS.  40  /~1  of these 
aliquots of purified, reduced, or reduced and column-fractionated B6-Ts3-8 
factors were added to NP-KLH-primed or normal responder cells challenged 
4 d previously with NP-Ficoll  or SRBC, respectively.  1 d later, all cultures 
were assayed for direct NP- or SRBC-specific  PFC responses. 
The data from four experiments are presented as the arithmetic mean of the 
percent suppression  relative  to PBS controls -+ SE. 
§ Significant level of suppression  relative  to the percent suppression  obtained 
with reduced, NP-BSA-binding fractions. 
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TABLE  VIII 
B6-Tsa-8 Factor Suppresses the NP-BA Response* 
PFC/culture •  log SE~: 
Supernatant added 
NP specific  TNP specific 
BW5147  1650  ÷  ×  1.1  600  +X  1.3 
B6-Tsa-8  220  +X  1.6§  535  +X  1.0 
* 40 #1 of BW5147 thymoma or B6-Tss-8 hybridoma culture supernatants were 
added  to  anti-Thyl.2 plus  C-treated NP-KLH-primed responder ceils or 
untreated TNP-KLH-primed responder cells 3 d after challenge with NP- 
BA or TNP-BA. All cultures were assayed  for NP- or TNP-specific direct 
PFC responses 5 d after antigenic challenge.  TsF1 was not included because 
this  factor will  not suppress  when added  to  anti-Thy-l.2 plus  C-treated 
cultures. 
:~ Data  are  expressed  as  the geometric mean  .X.  log  SE  from  six  to  eight 
experiments. 
§ Significant level of suppression  relative  to BW 5147 controls,  P <  0.03. 
response. The  data indicate that the B6-Tsa-8 suppressor factor, like some other TsF 
molecules  (14,  15,  17,  19)  exists as  a  two-chain structure.  Whereas one chain  binds 
antigen,  both  chains  are  required  to  manifest suppression.  The  suppression of the 
reconstituted Tsa is NP specific since the response to SRBC  remains unaffected. 
B6-Tsa-8 Hybridoma Supernatant Suppresses T-Independent Responses.  Although the B6- 
Tsa-8  factor  functions  during  the  effector  phase  of the  response,  it  is  not  known 
whether it  interacts directly with  the B  cell target.  To  determine whether  B6-Ts3-8 
factor is capable of suppressing a  B  cell response in the absence of T  cells, NP-primed 
responder cells were treated with anti-Thy-l.2 antiserum plus C  before challenge with 524  SUPPRESSION OF B CELL RESPONSES 
the class I thymus-independent antigen NP-BA (20). The antiserum used to lyse Thy- 
1.2-bearing T  cells consistently eliminated the capacity of NP-primed ceils to respond 
to  the  thymus-dependent  antigens  NP-GLdp and  NP-ovalbumin  in  vitro  (data  not 
shown).  When  supernatants  from B6-Tsz-8 cultures  were  added  on  day 3  of a  5-d 
culture period, significant suppression of the response to NP-BA was observed (Table 
VIII). The specificity of this suppression was demonstrated by the inability of B6-Ts3- 
8 factor to affect the response to TNP-BA. The data are consistent with the hypothesis 
that  Thy-l.2-bearing cells  are  not  required  for  suppression  mediated  by  B6-Ts3-8 
supernatants. 
Discussion 
The  intravenous  injection  of NP-modified  syngeneic  spleen  cells  results  in  the 
specific suppression of both NP-specificCS and PFC responses (1-9). This suppression 
is mediated by at least three interacting T  cell subpopulations. NP-specific first-order 
suppressor cells (Tsl) induce second-order suppressor cells (Ts2), which are specific for 
NPb-related idiotypic determinants. The Ts2 population activates an NP-primed, NP- 
specific third-order T  cell population  (Ts3) to effect immune suppression within 24 h 
of either the CS or the PFC assay. Taken together, the data suggest that a common 
T  cell  pathway  may  be  responsible  for  suppression  of  both  the  T  and  B  cell 
compartments. 
The purpose of the present study was to identify soluble factors derived from cloned 
Ts hybridoma cell lines that are capable of suppressing T  cell-mediated CS responses 
as well as directly suppressing B cell (PFC) responses. Despite the similarities between 
the in vitro PFC and the CS system, factors secreted by these T  cell populations had 
been defined only in the CS system. Because mixed populations of T  cells were used 
to suppress PFC responses in previous studies (5,  7, 9), it was not known whether the 
same cells or cellular products could regulate both T  cell-mediated CS  and  B  cell- 
mediated PFC responses. 
B6-Tsl-29 suppressor factor is derived from a  hybridoma isolated from spleens of 
NP spleen-treated C57BL/6 mice (2).  This factor has been well characterized in the 
CS  system  (2,  4).  Factor  present  in  supernatants  of B6-Tsx-29 hybridoma cells  (a) 
functions  only when  added  in  the  induction  phase of the CS  response,  (b)  induces 
effector-phase suppressor cells when injected i.v., (c) binds NP, (d) bears Npb-related 
and I-jb-encoded determinants,  and  (e)  can function  across H-2 and Igh disparities 
(2).  Similar results,  presented  in  the current  report, were obtained  in  a  PFC  assay 
system.  Thus,  the  cloned  B6-Tsl-29  hybridoma-derived  factor  (a)  is  capable  of 
suppressing  the  B  cell-mediated  PFC  response  only when  added  in  the  induction 
phase (day 0) of the Mishell-Dutton culture, (b) induces effector-phase suppressor cells 
in vitro, (c) binds NP, and (d) bears NP  b idiotype-related and I-olD-encoded determi- 
nants. 
In a similar fashion, a factor present in supernatants of B6-Tsz-8 hybridoma cultures 
has now been characterized in both the CS and in vitro PFC systems. In both systems 
the factor binds NP but not NP  u idiotypic determinants and bears 1-jb-encoded and 
NP  b idiotype-related determinants.  B6-Ts3-8 supernatants  have been shown to sup- 
press  CS  responses  only  in  the  effector  phase  of  the  response  (4),  whereas  data 
presented  in  this  report  demonstrate  that  B6-Tsa-8 supernatant  can  affect in  vitro 
PFC  responses  when  added  either  in  the  induction  or  the  effector phase.  Similar SHERR, MINAMI, OKUDA, AND DORF  525 
kinetics of TsF3 activity were reported by Waltenbaugh  and  Lei  (26)  using a  GT- 
specific TsF. Although the reason for this disparity between the kinetics of TsF3 in CS 
and  PFC  responses  is  not  known,  it  is  possible  that  the  in  vivo  half-life  of the 
suppressor factor is relatively short. Nevertheless, the data indicate that monoclonal 
B6-Ts3-8 derived factor can affect both T- and B cell-mediated responses. 
Given the  immunochemieal  similarity of B6-Tsl-29  and  B6-Tsa-8  factors it  was 
necessary to  provide evidence that  the  two  hybridomas  represent  different T  cell 
populations.  The B6-Tsa-8 factor is effective when added to responder populations 
either at the time of antigen challenge or within 18-24 h of the PFC assay. In contrast, 
in the PFC, as in the CS, system (2), the B6-Tsl-29 factor appears to work only when 
added in the induction phase. This difference presumably reflects the requirement for 
the Tsl-derived factor to recruit Ts2 cells to mediate suppression. This interpretation 
is  consistent  with  data  indicating  that  only the Tsa  factor is  capable  of inducing 
second-order, effeetor-phase suppressor cells in normal spleen cell cultures (Table V). 
The  ability  of hapten-binding  Ts~-derived  factor to  recruit  suppressor  cells  from 
normal  populations is  reminiscent of other suppressor cell systems  (21-25).  Unlike 
some factors described in other systems (21-22), the B6-Tsl-29-derived factor does not 
require antigen to induce second-order Ts cell populations. The induction of effector- 
phase suppressor cells with B6-Ts1-29 factor is further reflected by the inability of B6- 
Tsa-29 supernatants  to suppress responder cultures depleted of cells expressing I-J- 
encoded determinants. The inhibition of effector cell induction under these conditions 
may be due to elimination of Ts2 or Ts3 cell populations, because both of these cell 
types express I-J subregion-encoded determinants (5, 9). 
Both the B6-Tsl-29 and the B6-Tss-8 suppressor factors bind NP and express I-J  b- 
and Npb-related idiotypic determinants. Whether the I-J determinants expressed on 
the two factors are identical is not known. In this regard, it has recently been shown 
that the I-J subregion may code for more than one product, which are expressed to 
varying degrees on different populations of T  cells (26). Similarly, it remains to be 
determined whether these two distinct cell types within  the NP-specific suppressor 
cell pathway express the same or different NPb-related idiotypic determinants. It may 
be argued  that  the anti-NP  b idiotype antiserum  used  to adsorb  TsF may contain 
specificities for several components of the Npb-related idiotypic family, only some of 
which may be expressed on any monoclonal suppressor factor. In this regard, we have 
recently demonstrated  that,  although  anti-NP  b idiotypic antiserum  may recognize 
Npb-related determinants on both NP-specific T and B lymphocytes, the NP  b idiotype- 
related determinants expressed on Ts do not  appear to represent the predominant 
NP  b idiotypic determinants expressed on NP-specific antibody-producing cells (8). 
Unlike the donors for previously described Ts3 populations, the donors of spleen 
cells for fusion with BW5147 thymoma cells were not immunized subcutaneously or 
intraperitoneally with  NP-KLH  or  NP-O-Su.  Rather,  these  donors  were  injected 
intravenously with NP-coupled syngeneic spleen cells.  Spleen cells from mice treated 
7  d  previously with  NP-coupled  syngenic  spleen  cells  contain  both  Ts~  and  Ts2 
suppressor cell populations, which can be identified in the CS and/or PFC systems 
(1-8).  We have not  previously observed Ts3  cell generation  following intravenous 
sensitization, although Ts3 cells can be generated after subcutaneous administration 
of NP-coupled cells (16). Thus, the identification of a Tsa hybridoma cell line derived 
from  mice  given  NP-coupled  spleen  cells  intravenously  indicates  that  all  three 526  SUPPRESSION OF B CELL RESPONSES 
suppressor T  cell populations may exist  simultaneously.  However, the  frequency of 
Ts3 cells in these mice appears to be very low, since only one Ts3 hybridoma has been 
identified  in three fusions and since Ts2 cells  obtained from NP spleen-treated  mice 
require an exogenous source of Ts3 cells to effect significant suppression  (9). 
The  ability  of supernatants  from  B6-Tsa-8  hybridoma  cultures  to  suppress  the 
response of populations depleted of I-J-bearing cells  is consistent with the hypothesis 
that this factor represents the effector molecule in the suppressor pathway. The ability 
of B6-Tsa-8 supernatant  to suppress the T  independent  response to NP-BA suggests 
that this factor acts directly on B lymphocytes. The data do not, however, exclude the 
possibility that  an acceptor cell is required  for binding of the suppressor factor and 
manifestation  of  its  suppressor  function  (27).  If an  acceptor  cell  is  required  for 
suppression  mediated by Tsa  factor then  it  expresses  neither  I-J nor Thy-l.2 deter- 
minants, since the B6-Tsa-8 suppressor factor functions in anti-I-J antiserum plus C- 
treated responder cell cultures challenged with NP-Ficoll (Table VI) or anti-Thy-1.2 
antiserum  plus  C-treated  cultures  responding to  the class  I  T-independent  antigen 
NP-BA (Table VIII). If the Tsa factor acts directly on B lymphocytes then preferential 
suppression  of NP  b  idiotype  B  cell  clones  may  be  attributed  to  the  preferential 
inactivation of high affinity Npb-bearing B cells  by complexes of Tsa factor and NP 
antigen. This hypothesis is currently under investigation. 
It is conceivable that some antigen-binding factors may specifically inhibit in vitro 
generated responses by sequestering antigen and thereby making it unavailable to the 
responding cell  populations.  We can exclude the  possibility that  B6-Tsa-29-derived 
factor functions by depleting  antigen,  because  the  addition  of this  factor to  naive 
spleen  cells  in  the  absence  of antigen  results  in  the  generation  of a  population  of 
second-order T  suppressor cells.  Furthermore,  the addition of TsF1,  to Ts3-depleted 
cultures  fails  to mediate suppression.  It  is  also  unlikely  that  B6-Ts3-8  functions by 
depleting antigen, because the addition of this factor to cultures in the effector phase 
of the response results in significant suppression. This conclusion is further supported 
by  the  observation  that  the  isolated  antigen-binding  chains  of the  reduced  factor 
failed to effect suppression. 
Reduction  of B6-Ts3-8  factor with  DTT  resulted  in  two  moieties  that  could be 
separated  on  NP-BSA  immunoadsorbent  columns  (Table  VII).  Although  neither 
fraction alone significantly suppressed immune responsiveness, a combination of them 
reconstituted  suppression.  These  data are  taken  to reflect a  dimer structure  of this 
Tsa-derived  factor.  One  chain  contains  the  receptor  for  NP,  but  both  chains  are 
required  to  deliver  the  suppressor  signal.  Inasmuch  as  the  two  chains  were  not 
alkylated before reconstitution,  it  seems  likely that  interchain  disulfide  bonds were 
reformed and  that  the  active form of the  factor was regenerated by reconstitution. 
The two-polypeptide-chain concept may explain the observation that products linked 
to the Igh complex on the  12th chromosome (NP  b idiotype) and products encoded on 
the 17th chromosome (I-J b) are expressed on the same molecule or molecular complex 
(4). These data are consistent with those previously reported for KLH- (14),  SRBC- 
(18), and GT- (17) 2 specific effector suppressor factors. Recent data from our labora- 
tory also  demonstrates  that  the  TsF3  molecules, which  suppress  CS  responses,  also 
2 Lei, H-Y., S-T. Ju, M. E. Dorf, and C. Waltenbaugh. 1983. Regulation of immune responses by I-J 
gone products. III. GT-specific  suppressor factor is composed of separate I-J- and idiotype-bearing  chains. 
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consist of two chains, one with I-J encoded determinants and the other containing the 
NP-binding moieties (15). Thus, the TsFa molecules that suppress T  cell function have 
the same serological and  molecular properties as the TsFa molecules that  act on  B 
cells. 
This  report  establishes  the  ability  of  two  distinct  cloned  hybridoma  products 
representing TsFx and TsF~, respectively, to suppress PFC responses in a  manner as 
yet indistinguishable  from that observed in the CS sytem. Thus, suppression of both 
T  cell-mediated CS  and  B  cell-mediated  PFC  responses is effeeted with  molecules 
which, except for kinetic differences, have similar properties. 
Summary 
The  ability  of two  cloned  T  cell  hybridomas  and  their  products  to  specifically 
suppress  the  in  vitro plaque-forming cell  (PFC)  response to the 4-hydroxy-3-nitro- 
phenyl acetyl hapten (NP) was studied.  Supernatant  from one hybridoma (Tsl) was 
shown to suppress in the induction but not the effector phase of the immune response. 
Supernatant  from the  TSl  hybridoma was  capable of inducing  second-order  (Ts2) 
effector-phase suppressor cells in vitro but did not suppress the response of anti-I-J 
plus  C-treated  responder  cells.  In  contrast,  supernatant  from a  second  hybridoma 
(Ts3) was capable of suppressing PFC responses when added either in the induction 
or the effector phase of the response. Ts3 supernatant was unable to induce effector- 
phase suppressor cells but was capable of suppressing the response of anti-I-J plus C- 
treated  responder cells.  In addition,  specific suppressor factors isolated  from super- 
natants of the Tsl and Ts~ hybridomas were shown to bind to NP, bear NP  b idiotypic 
and/-J-encoded but not  immunoglobulin-constant  region determinants.  The factor 
secreted by the Tsa hybridoma appears to act directly on B cell targets. Mild reduction 
of this factor results in two separable moieties, only one of which binds NP.  Recon- 
stitution experiments suggest that both chains are required for function. The collective 
data  indicate  that  these  hybridomas  represent  cells  from  first-  and  third-order 
suppressor T  cell populations described previously in contact sensitivity and in vitro 
PFC  systems. The implications of the ability of these hybridoma products to affect 
both T  and B cell-mediated immune responses are discussed. 
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